BRPI0919342A2 - derivados do isoxazol [4,5] piridin-3-il-piperazina, seu processo de preparação, seu medicamento e seu uso - Google Patents
derivados do isoxazol [4,5] piridin-3-il-piperazina, seu processo de preparação, seu medicamento e seu usoInfo
- Publication number
- BRPI0919342A2 BRPI0919342A2 BRPI0919342A BRPI0919342A BRPI0919342A2 BR PI0919342 A2 BRPI0919342 A2 BR PI0919342A2 BR PI0919342 A BRPI0919342 A BR PI0919342A BR PI0919342 A BRPI0919342 A BR PI0919342A BR PI0919342 A2 BRPI0919342 A2 BR PI0919342A2
- Authority
- BR
- Brazil
- Prior art keywords
- isoxazole
- pyridin
- medicine
- preparation process
- piperazine derivatives
- Prior art date
Links
- DNDJHEWLYGJJCY-UHFFFAOYSA-N 1-pyridin-3-ylpiperazine Chemical class C1CNCCN1C1=CC=CN=C1 DNDJHEWLYGJJCY-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08164904 | 2008-09-23 | ||
| PCT/EP2009/061965 WO2010034656A1 (en) | 2008-09-23 | 2009-09-15 | Isoxazolo[4,5]pyridin-3-yl-piperazin derivatives useful as modulatorsof dopamine d3 receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0919342A2 true BRPI0919342A2 (pt) | 2015-12-29 |
Family
ID=41397376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0919342A BRPI0919342A2 (pt) | 2008-09-23 | 2009-09-15 | derivados do isoxazol [4,5] piridin-3-il-piperazina, seu processo de preparação, seu medicamento e seu uso |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7825123B2 (pt) |
| EP (1) | EP2337783A1 (pt) |
| JP (1) | JP2012502948A (pt) |
| KR (1) | KR20110076944A (pt) |
| CN (1) | CN102164927A (pt) |
| AU (1) | AU2009296055A1 (pt) |
| BR (1) | BRPI0919342A2 (pt) |
| CA (1) | CA2737252A1 (pt) |
| IL (1) | IL211565A0 (pt) |
| MX (1) | MX2011002755A (pt) |
| WO (1) | WO2010034656A1 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2736724A1 (en) * | 2008-09-23 | 2010-04-01 | F.Hoffmann-La Roche Ag | Benzo[d]isoxazol-3-yl-piperazin derivatives useful as modulators of dopamine d3 receptors |
| US8586579B2 (en) * | 2010-06-21 | 2013-11-19 | Hoffmann-La Roche Inc. | Anellated pyridine compounds |
| US8470828B2 (en) | 2010-07-06 | 2013-06-25 | Hoffmann-La Roche Inc. | Anellated pyridine compounds |
| US8877778B2 (en) | 2010-12-15 | 2014-11-04 | Hoffmann-La Roche Inc. | Benzofurane compounds |
| US8921397B2 (en) * | 2011-05-04 | 2014-12-30 | Hoffmann-La Roche Inc. | Benzofurane-piperidine compounds |
| CA2949173A1 (en) * | 2014-06-03 | 2015-12-10 | Caterina Bissantz | Peptides as oxytocin agonists |
| CR20160562A (es) * | 2014-06-06 | 2017-01-06 | Hoffmann La Roche | Péptidos como agonistas de la oxitocina |
| CN106518841B (zh) | 2015-09-15 | 2019-03-05 | 浙江京新药业股份有限公司 | 环己烷衍生物或其立体异构体或盐及其制备与应用 |
| WO2017045599A1 (zh) * | 2015-09-15 | 2017-03-23 | 浙江京新药业股份有限公司 | 环己烷衍生物或其立体异构体或盐及其制备与应用 |
| EP3495363B1 (en) | 2016-07-28 | 2023-08-23 | Shionogi & Co., Ltd | Nitrogen-containing condensed ring compounds having dopamine d3 receptor antagonistic effect |
| US11447484B2 (en) | 2018-01-26 | 2022-09-20 | Shionogi & Co., Ltd. | Cyclic compound having dopamine D3 receptor antagonistic effect |
| CA3089498A1 (en) | 2018-01-26 | 2019-08-01 | Shionogi & Co., Ltd. | Condensed ring compounds having dopamine d3 receptor antagonistic effect |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ230045A (en) * | 1988-08-05 | 1990-11-27 | Janssen Pharmaceutica Nv | 3-piperazinylbenzazole derivatives and pharmaceutical compositions |
| ES2157442T3 (es) * | 1995-06-06 | 2001-08-16 | Aventis Pharma Inc | Derivados de benzoisoxazol y de indazol, utilizados como agentes neurolepticos. |
| FR2749304B1 (fr) * | 1996-06-04 | 1998-06-26 | Adir | Nouveaux derives du 3-(piperid-4-yl)1,2-benzisoxazole et du 3-(piperazin-4-yl)1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
| EP1870405A1 (en) * | 2006-06-22 | 2007-12-26 | Bioprojet | Carbonylated (Aza)cyclohexanes as dopamine D3 receptor ligands |
| ES2498673T3 (es) * | 2007-07-26 | 2014-09-25 | F. Hoffmann-La Roche Ag | Moduladores duales de los receptores 5-HT2a y D3 |
| CN102159557A (zh) * | 2008-09-22 | 2011-08-17 | 弗·哈夫曼-拉罗切有限公司 | 哌嗪d3和5-ht2a受体调节剂 |
| CA2736724A1 (en) * | 2008-09-23 | 2010-04-01 | F.Hoffmann-La Roche Ag | Benzo[d]isoxazol-3-yl-piperazin derivatives useful as modulators of dopamine d3 receptors |
-
2009
- 2009-09-15 CA CA2737252A patent/CA2737252A1/en not_active Abandoned
- 2009-09-15 AU AU2009296055A patent/AU2009296055A1/en not_active Abandoned
- 2009-09-15 EP EP09783045A patent/EP2337783A1/en not_active Withdrawn
- 2009-09-15 BR BRPI0919342A patent/BRPI0919342A2/pt not_active IP Right Cessation
- 2009-09-15 CN CN2009801374146A patent/CN102164927A/zh active Pending
- 2009-09-15 JP JP2011527304A patent/JP2012502948A/ja active Pending
- 2009-09-15 WO PCT/EP2009/061965 patent/WO2010034656A1/en not_active Ceased
- 2009-09-15 MX MX2011002755A patent/MX2011002755A/es active IP Right Grant
- 2009-09-15 KR KR1020117008913A patent/KR20110076944A/ko not_active Withdrawn
- 2009-09-17 US US12/561,497 patent/US7825123B2/en not_active Expired - Fee Related
-
2011
- 2011-03-03 IL IL211565A patent/IL211565A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20100075981A1 (en) | 2010-03-25 |
| JP2012502948A (ja) | 2012-02-02 |
| EP2337783A1 (en) | 2011-06-29 |
| CN102164927A (zh) | 2011-08-24 |
| WO2010034656A1 (en) | 2010-04-01 |
| KR20110076944A (ko) | 2011-07-06 |
| IL211565A0 (en) | 2011-05-31 |
| MX2011002755A (es) | 2011-04-07 |
| US7825123B2 (en) | 2010-11-02 |
| CA2737252A1 (en) | 2010-04-01 |
| AU2009296055A1 (en) | 2010-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1009481A2 (pt) | compostos de 2-acetamido-5-aril-1,2,4-triazolonas substituídas, seu processo de preparação, seu uso e medicamento compreendendo os mesmos | |
| BR112012006404A2 (pt) | derivados de di-hidropteridinona, processo de preparação e uso farmacêutico dos mesmos | |
| BRPI0924427A2 (pt) | composição farmacêutica de liberação controlada, seu processo de preparação e uso da mesma | |
| BRPI0905663A2 (pt) | "emulsão estável, processo de preparação da emulsão estável e uso emulsão" | |
| BRPI0812851A2 (pt) | Composto, composição farmacêutica, métodos para o tratamento de uma doença e de uma condição em um indivíduo, processo para preparar um composto, e, uso de um composto | |
| HUS1700034I1 (hu) | Izoxazolin-származékok és peszticidként történõ alkalmazásuk | |
| BRPI0815606A2 (pt) | Derivados de 6-triazol piridazina - sulfanil benzotiazol e benzimidazol, o respectivo processo de preparo, a respectiva aplicação a título de medicamentos, composições farmacêuticas e utilização, notadamente como inibidores de met. | |
| BRPI1006162A2 (pt) | "composto,processo para preparar um composto,formulação farmacêutica,e uso de um composto". | |
| BRPI0721148A2 (pt) | Nanopartículas magnéticas para aplicação em hipertermia, preparação destas e uso de construtos apresentando aplicação farmacológica. | |
| BRPI0813455A2 (pt) | Derivado de 17beta-ciano-18a-homo-19-nor-androst-4-eno, seu uso e medicamentos contendo este derivado. | |
| BRPI1008045A2 (pt) | derivados de aminotetralina, composições farmacêuticas contendo-os, e seu uso em terapia | |
| BRPI0811865A2 (pt) | Derivados heterocíclicos pirrolo-nitrogenados, a preparação e o uso farmacêutico dos mesmos | |
| BRPI1010621A2 (pt) | derivado de imidazoquinolinonas, sua composição farmacêutica e seu uso | |
| BRPI0707991B8 (pt) | métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco | |
| BRPI0821440A2 (pt) | Derivados de tetra-hidro-imidazo[1,5-a] pirazina, processo de preparação e uso medicinal dos mesmos | |
| BRPI0915552A2 (pt) | derivados de ciclosporina, seu uso e sua composição farmacêutica | |
| BRPI0907892A2 (pt) | Composto antibiótico azatricíclico, medicamento, composição farmacêutica que o contém e uso do mesmo | |
| BR112012001344A2 (pt) | derivados de 17hidróxi-17-pentafluoroetil-estra-4,9(10)-dieno-11-arila, método de produção destes e uso destes para o tratamento de doenças | |
| BR112013031210A2 (pt) | processo para o tratamento das fibras queratínicas, kit e uso de um dispositivo | |
| BRPI0822946A2 (pt) | Derivado de carboxiamida, processo para preparação de derivado de carboxiamida, composição farmacêutica e uso do derivado de carboxiamida | |
| BRPI0813427A2 (pt) | Composto, uso do mesmo, método para tratar a infecção bacteriana em um animal de sangue quente, composição farmacêutica, e, processo para a preparação de um composto. | |
| FR2940284B1 (fr) | Derives de 6-cycloamino-2,3-di-pyridinyl-imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique | |
| BRPI0906727A2 (pt) | Azaindol-3-carboxamidas cíclicas, sua preparação e seu uso como produtos farmacêuticos | |
| BRPI0810461A2 (pt) | Combinação de drogas e seu uso no tratamento de perda muscular | |
| BRPI0813937A2 (pt) | Derivado de 17beta-ciano-19-nor-andros-4-eno, seu uso e medicamentos contendo o derivado |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2376 DE 19-07-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |